An independent LDT provider
Vision and mission
Board of directors
Medical Advisory Board
Patient Advocacy Support
Immunovia Dx Laboratory, Lund
Code of conduct
Pancreatic cancer high risk groups
Clinical prospective study program
Current technologies for detection and diagnosis
March 30, 2021
Immunovia reports historical breakthrough in early detection of...
December 1, 2020
Immunovia webcasted telephone conference with Patrik Dahlen, CEO,...
October 26, 2020
Immunovia call: Verification & Validation Update and Q&A,...
May 27, 2020
Immunovia COVID-19 Update with Mats Grahn, CEO Immunovia, May 27, 2020
May 13, 2020
Immunovia COVID-19 Update with Mats Grahn, CEO Immunovia, May 13, 2020
April 1, 2020
Immunovia update call on the update on the company’s COVID-19...
June 3, 2019
Immunovia update call on the optimization study results with Mats...
April 29, 2019
Immunovia Update call with Mats Grahn, CEO Immunovia, April 29, 2019
March 4, 2019
Telephone conference with Mats Grahn, CEO Immunovia, March 4, 2019
October 8, 2018
Telephone conference with Mats Grahn, CEO, and Laura Chirica, CCO,...
August 17, 2018
Telephone conference with Mats Grahn, CEO Immunovia, August 17, 2018
August 9, 2018
Telephone conference with Mats Grahn, CEO Immunovia and Henrik...